crainalerts

Sep 5, 2024, 04:00 PM UTC

AbbVie has immunology competition

Having trouble viewing this email? See the online version Don't Miss Thursday, September 05, 2024 Closeup of Eli Lilly's GLP-1 Zepbound As obesity drugs reshape the pharma world, Eli Lilly eyes

AbbVie has immunology competition

Having trouble viewing this email? See the online version

Don’t Miss

Thursday, September 05, 2024
Closeup of Eli Lilly's GLP-1 Zepbound

As obesity drugs reshape the pharma world, Eli Lilly eyes AbbVie's wheelhouse

The North Chicago drugmaker could have a new foe — or frenemy — in a fellow Big Pharma firm trying to find wider uses for its GLP-1.

Read More >

Did someone forward this to you? Sign up for our newsletters and email alerts here.

UNLOCK YOUR ACCESS

Discover the latest insights, analysis & opinion needed to navigate Chicago's complex business landscape.

VIEW OUR SUBSCRIPTION OFFERS
 

This email was sent to -
Manage My Account | Contact Us

 

© 2024 Crain Communications Inc
130 E. Randolph St., Suite 3200, Chicago, IL 60601 United States
Privacy Policy | Terms and Conditions | Unsubscribe

 

Latest Emails from crainalerts

See more